273 related articles for article (PubMed ID: 33524197)
1. Insulin's other life: an autoantigen in type 1 diabetes.
Mannering SI; Bhattacharjee P
Immunol Cell Biol; 2021 May; 99(5):448-460. PubMed ID: 33524197
[TBL] [Abstract][Full Text] [Related]
2. Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets.
Rodriguez-Calvo T; Johnson JD; Overbergh L; Dunne JL
Front Immunol; 2021; 12():667989. PubMed ID: 33953728
[TBL] [Abstract][Full Text] [Related]
3. Maternal Type 1 Diabetes Reduces Autoantigen-Responsive CD4
Knoop J; Eugster A; Gavrisan A; Lickert R; Sedlmeier EM; Dietz S; Lindner A; Warncke K; Hummel N; Ziegler AG; Bonifacio E
Diabetes; 2020 Apr; 69(4):661-669. PubMed ID: 31896551
[TBL] [Abstract][Full Text] [Related]
4. Proinsulin-a pathogenic autoantigen in type 1 diabetes.
Narendran P; Mannering SI; Harrison LC
Autoimmun Rev; 2003 Jun; 2(4):204-10. PubMed ID: 12848947
[TBL] [Abstract][Full Text] [Related]
5. Identifying New Hybrid Insulin Peptides (HIPs) in Type 1 Diabetes.
Mannering SI; Rubin AF; Wang R; Bhattacharjee P
Front Immunol; 2021; 12():667870. PubMed ID: 33995402
[TBL] [Abstract][Full Text] [Related]
6. Neoepitopes: a new take on beta cell autoimmunity in type 1 diabetes.
Mannering SI; Di Carluccio AR; Elso CM
Diabetologia; 2019 Mar; 62(3):351-356. PubMed ID: 30402774
[TBL] [Abstract][Full Text] [Related]
7. Proinsulin C-peptide is an autoantigen in people with type 1 diabetes.
So M; Elso CM; Tresoldi E; Pakusch M; Pathiraja V; Wentworth JM; Harrison LC; Krishnamurthy B; Thomas HE; Rodda C; Cameron FJ; McMahon J; Kay TWH; Mannering SI
Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10732-10737. PubMed ID: 30275329
[TBL] [Abstract][Full Text] [Related]
8. The dark side of insulin: A primary autoantigen and instrument of self-destruction in type 1 diabetes.
Harrison LC
Mol Metab; 2021 Oct; 52():101288. PubMed ID: 34242821
[TBL] [Abstract][Full Text] [Related]
9. Type 1 diabetes mellitus: much progress, many opportunities.
Powers AC
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33759815
[TBL] [Abstract][Full Text] [Related]
10. The targeting of β-cells by T lymphocytes in human type 1 diabetes: clinical perspectives.
Luce S; Briet C; Bécourt C; Lemonnier F; Boitard C
Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():89-97. PubMed ID: 24003925
[TBL] [Abstract][Full Text] [Related]
11. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
12. The case for an autoimmune aetiology of type 1 diabetes.
Mannering SI; Pathiraja V; Kay TW
Clin Exp Immunol; 2016 Jan; 183(1):8-15. PubMed ID: 26313217
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune mechanisms in type 1 diabetes.
Knip M; Siljander H
Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
[TBL] [Abstract][Full Text] [Related]
14. Induction of islet autoimmunity to defective ribosomal product of the insulin gene as neoantigen after anti-cancer immunotherapy leading to autoimmune diabetes.
van Tienhoven R; Jansen DTSL; Park M; Williams JC; Larkin J; Quezada SA; Roep BO
Front Immunol; 2024; 15():1384406. PubMed ID: 38596681
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the Pathogenesis of Human Type 1 Diabetes (T1D) by Interrogating T Cells from the "Scene of the Crime".
Kent SC; Mannering SI; Michels AW; Babon JAB
Curr Diab Rep; 2017 Sep; 17(10):95. PubMed ID: 28864875
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
Durinovic-Belló I
Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
[TBL] [Abstract][Full Text] [Related]
17. Changing faces, unmasking the beta-cell: post-translational modification of antigens in type 1 diabetes.
van Lummel M; Zaldumbide A; Roep BO
Curr Opin Endocrinol Diabetes Obes; 2013 Aug; 20(4):299-306. PubMed ID: 23770733
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of autoimmunity and beta cell metabolism in type 1 diabetes.
Yang ML; Kibbey RG; Mamula MJ
Front Immunol; 2022; 13():1028130. PubMed ID: 36389721
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
20. A century later, still fighting back: antigen-specific immunotherapies for type 1 diabetes.
Rodriguez-Fernandez S; Almenara-Fuentes L; Perna-Barrull D; Barneda B; Vives-Pi M
Immunol Cell Biol; 2021 May; 99(5):461-474. PubMed ID: 33483995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
